Synthesis and antibacterial activities of amphiphilic neomycin B-based bilipid conjugates and fluorinated neomycin B-based lipids

Molecules

Volumn 17, Issue 8, 2012, Pages 9129-9141

  Bera, Smritilekha ^a,b   Dhondikubeer, Ramesh ^a   Findlay, Brandon ^a   Zhanel, George G ^a   Schweizer, Frank ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CENTRAL UNIVERSITY OF GUJARAT   (India)

Author keywords

Aminoglycosides; Antibacterials; Carbohydrates; Cationic amphiphiles

Indexed keywords

ANTIINFECTIVE AGENT; DRUG DERIVATIVE; FLUORINATED HYDROCARBON; FRAMYCETIN; GUANIDINE DERIVATIVE; LIPID; SURFACTANT;

ARTICLE; CHEMISTRY; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MICROBIAL SENSITIVITY TEST; SYNTHESIS;

ANTI-BACTERIAL AGENTS; FRAMYCETIN; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; GUANIDINES; HYDROCARBONS, FLUORINATED; LIPIDS; MICROBIAL SENSITIVITY TESTS; SURFACE-ACTIVE AGENTS;

EID: 84865506551     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17089129     Document Type: Article

References (20)

1. Tadesse, D.A.; Zhao, S.; Tong, E.; Ayers, S.; Singh, A.; Bartholomew, M.J.; McDermott, P.F. Antimicrobial Drug Resistance in Escherichia Coli from Humans and Food Animals, United States, 1950-2002. Emerg. Infect. Dis. 2012, 18, 741-749.
2. Fontes, L.C.; Neves, P.R.; Oliveira, S.; Silva, K.C.; Hachich, E.M.; Sato, M.I.; Lincopan, N. Isolation of Pseudomonas Aeruginosa Coproducing Metallo-Beta-Lactamase SPM-1 and 16S rRNA Methylase RmtD1 in an Urban River. Antimicrob. Agents Chemother. 2011, 55, 3063-3064.
3. McDonnell, G.; Russell, A.D. Antiseptics and Disinfectants: Activity, Action, and Resistance. Clin. Microbiol. Rev. 1999, 12, 147-179.
4. Lipsky, B.A.; Holroyd, K.J.; Zasloff, M. Topical Versus Systemic Antimicrobial Therapy for Treating Mildly Infected Diabetic Foot Ulcers: A Randomized, Controlled, Double-Blinded, Multicenter Trial of Pexiganan Cream. Clin. Infect. Dis. 2008, 47, 1537-1545.
5. Findlay, B.; Zhanel, G.G.; Schweizer, F. Cationic Amphiphiles, a New Generation of Antimicrobials Inspired by the Natural Antimicrobial Peptide Scaffold. Antimicrob. Agents Chemother. 2010, 54, 4049-4058.
6. Brogden, K.A. Antimicrobial Peptides: Pore Formers Or Metabolic Inhibitors in Bacteria? Nat. Rev. Microbiol. 2005, 3, 238-250.
7. Yeung, A.T.; Gellatly, S.L.; Hancock, R.E. Multifunctional Cationic Host Defence Peptides and their Clinical Applications. Cell Mol. Life Sci. 2011, 68, 2161-2176.
8. Bera, S.; Zhanel, G.G.; Schweizer, F. Synthesis and Antibacterial Activity of Amphiphilic Lysine- Ligated Neomycin B Conjugates. Carbohydr. Res. 2011, 346, 560-568.
9. Bera, S.; Zhanel, G.G.; Schweizer, F. Antibacterial Activity of Guanidinylated Neomycin B- and Kanamycin A-Derived Amphiphilic Lipid Conjugates. J. Antimicrob. Chemother. 2010, 65, 1224-1227.
10. Bera, S.; Zhanel, G.G.; Schweizer, F. Antibacterial Activities of Aminoglycoside Antibiotics- Derived Cationic Amphiphiles. Polyol-Modified Neomycin B-, Kanamycin A-, Amikacin-, and Neamine-Based Amphiphiles with Potent Broad Spectrum Antibacterial Activity. J. Med. Chem. 2010, 53, 3626-3631.
11. Bera, S.; Zhanel, G.G.; Schweizer, F. Evaluation of Amphiphilic Aminoglycoside-Peptide Triazole Conjugates as Antibacterial Agents. Bioorg. Med. Chem. Lett. 2010, 20, 3031-3035.
12. Bera, S.; Zhanel, G.G.; Schweizer, F. Design, Synthesis, and Antibacterial Activities of Neomycin-Lipid Conjugates: Polycationic Lipids with Potent Gram-Positive Activity. J. Med. Chem. 2008, 51, 6160-6164.
13. Francois, B.; Russell, R.J.; Murray, J.B.; Aboul-ela, F.; Masquida, B.; Vicens, Q.; Westhof, E. Crystal Structures of Complexes between Aminoglycosides and Decoding A Site Oligonucleotides: Role of the Number of Rings and Positive Charges in the Specific Binding Leading to Miscoding. Nucleic Acids Res. 2005, 33, 5677-5690.
14. Michael, K.; Wang, H.; Tor, Y. Enhanced RNA Binding of Dimerized Aminoglycosides. Bioorg. Med. Chem. 1999, 7, 1361-1371.
15. Findlay, B.; Zhanel, G.G.; Schweizer, F. Investigating the Antimicrobial Peptide "Window of Activity™ using Cationic Lipopeptides with Hydrocarbon and Fluorinated Tails. Int. J. Antimicrob. Agents 2012, 40, 36-42.
16. Baker, T.J.; Luedtke, N.W.; Tor, Y.; Goodman, M. Synthesis and Anti-HIV Activity of Guanidinoglycosides. J. Org. Chem. 2000, 65, 9054-9058.
17. Zhanel, G.G.; DeCorby, M.; Laing, N.; Weshnoweski, B.; Vashisht, R.; Tailor, F.; Nichol, K.A.; Wierzbowski, A.; Baudry, P.J.; Karlowsky, J.A.; et al. Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006. Antimicrob. Agents Chemother. 2008, 52, 1430-1437.
18. Zhang, J.; Chiang, F.I.; Wu, L.; Czyryca, P.G.; Li, D.; Chang, C.W. Surprising Alteration of Antibacterial Activity of 5"-Modified Neomycin Against Resistant Bacteria. J. Med. Chem. 2008, 51, 7563-7573.
19. Clinical and Laboratory Standard Institute. Document: M100-S16 CLSI.NCCLS; Clinical and Laboratory Standard Institute: Wayne, PA, USA, 2006.
20. Dathe, M.; Schumann, M.; Wieprecht, T.; Winkler, A.; Beyermann, M.; Krause, E.; Matsuzaki, K.; Murase, O.; Bienert, M. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 1996, 35, 12612-12622.